Pancreatic Cancer Research

ResearcherKansai Medical UniversityNo recent work listed

Tatsuma Sakaguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2246-9526; OpenAlex author ID A5051416234. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 7

  1. Survival impact of occult liver metastasis and peritoneal dissemination compared with radiologically defined distant organ metastasis in pancreatic ductal aden… First author DOI 10.1016/j.pan.2022.11.012↗
  2. A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jhbp.1026↗
  3. Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therap… Co-author DOI 10.1007/s00595-021-02308-3↗
  4. Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study. Co-author DOI 10.1016/j.pan.2021.03.008↗
  5. Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ags3.12295↗
  6. The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-020-01963-2↗
  7. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Co-author DOI 10.1016/j.pan.2019.05.466↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sohei Satoi · 7 shared papers, 2019–2023 · strength 0.97
  2. So Yamaki · 6 shared papers, 2020–2023 · strength 0.85
  3. Tomohisa Yamamoto · 6 shared papers, 2020–2023 · strength 0.85
  4. Mitsugu Sekimoto · 6 shared papers, 2020–2023 · strength 0.85
  5. Daisuke Hashimoto · 4 shared papers, 2021–2023 · strength 0.56
  6. Tsukasa Ikeura · 2 shared papers, 2022–2023 · strength 0.32
  7. Satoshi Hirooka · 2 shared papers, 2021–2022 · strength 0.28
  8. Hironori Ryota · 2 shared papers, 2021 · strength 0.24
  9. Yuki Matsui · 1 shared paper, 2023 · strength 0.17
  10. Roberto Valente · 1 shared paper, 2019 · strength 0.12
  11. Marco Del Chiaro · 1 shared paper, 2019 · strength 0.12
  12. Kenji Nakagawa · 1 shared paper, 2021 · strength 0.11
  13. Taichi Terai · 1 shared paper, 2021 · strength 0.11
  14. Masayuki Sho · 1 shared paper, 2021 · strength 0.11
  15. Tadataka Takagi · 1 shared paper, 2021 · strength 0.11
  16. Takahiro Akahori · 1 shared paper, 2021 · strength 0.11
  17. Minako Nagai · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.